University Of Notre Dame Du Lac Zymeworks Inc. Transaction History

University Of Notre Dame Du Lac

  • $72.3 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$33.67 - $40.0 $770,706 - $915,600
-22,890 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$24.28 - $49.8 $555,769 - $1.14 Million
22,890 New
22,890 $812,000

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $856M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track University Of Notre Dame Du Lac Portfolio

Follow University Of Notre Dame Du Lac and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

News

Stay updated on University Of Notre Dame Du Lac with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email